Pharmaceutical industy: Health ministers shouldn't be too hasty with new pharma strategy
The Danish Association of the Pharmaceutical Industry (Lif) has warned that the coronavirus should not be the starting point when EU ministers discuss new pharmaceutical strategies for Europe. The association believes that Europe cannot and should not do everything by itself.
BY LOUISE WENDT JENSEN, TRANSLATED BY CATHERINE BRETT
Stella Kyriakide, the EU health commissioner, had the following to say during a hearing for the European Parliament's health commisssion (ENVI):
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
.jpg)
